Toward the elimination of race-based medicine: replace race with racism as preeclampsia risk factor.
aspirin prophylaxis
health inequities
maternal morbidity and mortality
obstetrical outcomes
preeclampsia
race-based medicine
racism
Journal
American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
12
01
2022
revised:
17
05
2022
accepted:
23
05
2022
pubmed:
1
6
2022
medline:
5
10
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
Pregnancy-related morbidity and mortality continue to disproportionately affect birthing people who identify as Black. The use of race-based risk factors in medicine exacerbates racial health inequities by insinuating a false conflation that fails to consider the underlying impact of racism. As we work toward health equity, we must remove race as a risk factor in our guidelines to address disparities due to racism. This includes the most recent US Preventive Services Taskforce, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine guidelines for aspirin prophylaxis in preeclampsia, where the risk factor for "Black race" should be replaced with "anti-Black racism." In this commentary, we reviewed the evidence that supports race as a sociopolitical construct and the health impacts of racism. We presented a call to action to remove racial determination in the guidelines for aspirin prophylaxis in preeclampsia and more broadly in our practice of medicine.
Identifiants
pubmed: 35640703
pii: S0002-9378(22)00413-6
doi: 10.1016/j.ajog.2022.05.048
pii:
doi:
Substances chimiques
Aspirin
R16CO5Y76E
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
593-596Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.